TECX
TECX
NASDAQ · Biotechnology

Tectonic Therapeutic Inc

$27.00
-0.21 (-0.77%)
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Buy 15 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +37.9% upside
Low Target $31.47
Average Target $37.23
High Target $57.92
Current Price $27.00
Current
$27.00
Target
$37.23
$31.47 $37.23 avg $57.92
Scenario Analysis
Bear Case
$31.47
16.6%
Low target
Base Case
$37.23
+37.9%
Avg target
Bull Case
$57.92
+114.5%
High target
Risk/Reward
6.9x
Highly favorable
Price in Context
52-Week High
$39.53
-31.7% from high
52-Week Low
$14.39
+87.6% from low
Target vs 52W High
$37.23
-5.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.6%
AMGN
Amgen Inc
Hold 43 47% $190.87 -51.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +140.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -14.2%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
Hold 30 37% $149.45 -13.6%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -61.4%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -40.8%